Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1) [Phase 2]
This document reports the completion of a Phase 2 single-center clinical trial for moderate to severe allergic conjunctivitis using EBI-005-…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234) [Phase 2, Phase 3]
Clinical trial update reporting efficacy and long-term safety of a ragweed sublingual immunotherapy tablet (SCH 39641) in adults with ragwee…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) [Phase 2]
Phase 2 safety study of a ragweed pollen immunotherapy tablet in adults aged 50 and older (Study P06081) has completed, with results posted …
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: Safety and Efficacy of Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis in Korea
A completed Korean trial evaluating the safety and efficacy of Relestat Ophthalmic Solution 0.05% for allergic conjunctivitis, with results …
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: A Six-Week Safety Study of an Investigational Ophthalmic Solution [Phase 3]
A Phase 3 six-week safety study of an investigational ophthalmic solution for allergic conjunctivitis has completed and results were posted.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: AGN-229666 for the Treatment of Allergic Conjunctivitis [Phase 2]
Phase 2 clinical trial of AGN-229666 for allergic conjunctivitis completed; results were posted in February 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis [Phase 4]
Phase 4 study comparing Lastacaft (olopatadine) to Pataday (olopatadine) and placebo for efficacy in acute allergic conjunctivitis; results …
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Comparing Patient Satisfaction With Pataday or Bepreve [NA]
A completed clinical trial comparing patient satisfaction with Pataday (olopatadine) versus Bepreve (olopatadine) for eye allergies.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation [Phase 3]
A Phase 3 trial evaluating a high-dose sublingual grass pollen preparation shows efficacy and safety data in allergic rhinitis and allergic …
-
CLINICAL_TRIALS trial_result · 2013-09-10Clinical Trial Update: A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) [Phase 3]
Phase 3 trial evaluating SCH 697243 for grass pollen–related allergic rhinitis with allergic conjunctivitis, with or without asthma; results…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis [Phase 3]
Phase 3 trial assessing onset and duration of AKF-1 Ophthalmic Solution for acute allergic conjunctivitis has completed. The snippet does no…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial investigates whether the pollen season influences reactions to subcutaneous allergen immunotherapy in patie…
-
CLINICAL_TRIALS trial_result · 2013-05-23Clinical Trial Update: Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model [Phase 3]
Phase 3 trial evaluating the efficacy and safety of AL-4943A ophthalmic solution for allergic conjunctivitis; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis [Phase 3]
A Phase 3 study comparing topical bromfenac ophthalmic solution to placebo in allergic conjunctivitis has completed, assessing efficacy and …
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis [Phase 4]
This Phase 4 clinical trial update reports results from a study evaluating the efficacy of Maxidex and Patanol for allergic conjunctivitis.
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis [Phase 4]
Phase 4 study evaluating the duration of LASTACAFT (alcaftadine) in acute allergic conjunctivitis was completed. The results were posted in …
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients [Phase 2]
Phase 2 trial update evaluating pharmacodynamic parameters and tolerability of grass pollen subcutaneous immunotherapy in patients with alle…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Evaluation of the Onset and Duration of Action of RX-10045 in Allergic Conjunctivitis [Phase 2]
This clinical trial update summarizes a Phase 2 study assessing how quickly RX-10045 works and how long its effects last in allergic conjunc…
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of a sublingual immunotherapy solution for birch pollen–induced allergic rhinoconj…
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms [Phase 4]
Phase 4 study assessed the effect of fluticasone furoate nasal spray on spring allergy-related eye symptoms (allergic conjunctivitis) with c…
-
CLINICAL_TRIALS trial_result · 2012-09-18Clinical Trial Update: A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis [Phase 4]
Phase 4 trial evaluating patient perception and quality of life with olopatadine 0.2% for allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of a grass pollen sublingual tablet in children and adolescents with rhinoconjunctivitis/…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) [Phase 3]
Phase 3 trial results evaluate the efficacy and safety of a grass pollen sublingual tablet in adults with allergic rhinitis with conjunctivi…
-
CLINICAL_TRIALS trial_result · 2012-07-25Clinical Trial Update: Assessment of Alcon's Ocular Image Quantification System [Phase 4]
A Phase 4 clinical trial evaluating Alcon's Ocular Image Quantification System for allergic conjunctivitis has completed and results have be…
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis [Phase 4]
Phase 4 study evaluating patient perceptions and quality of life associated with using olopatadine 0.2% for allergic conjunctivitis; results…